Secondary acute myeloid leukemia after successful treatment for osteosarcoma

Secondary acute myeloid leukemia (sAML) is a rare complication following chemotherapy for osteogenic sarcoma. However, the exact offending drug is difficult to prove as there is no consistent data. It usually develops 2 years after completion of therapy. We report a case of sAML that developed withi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Rakesh, Ramaswamy, N. V., Pandita, R., Al Bahar, S., Khalifa, N., Omar, S.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941602/
https://www.ncbi.nlm.nih.gov/pubmed/20931020
http://dx.doi.org/10.4103/0971-5851.68852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941602/
https://www.ncbi.nlm.nih.gov/pubmed/20931020
http://dx.doi.org/10.4103/0971-5851.68852

Ejemplares similares